Je‐Hwan Lee

10.7k total citations
309 papers, 5.0k citations indexed

About

Je‐Hwan Lee is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Je‐Hwan Lee has authored 309 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Hematology, 69 papers in Oncology and 65 papers in Genetics. Recurrent topics in Je‐Hwan Lee's work include Acute Myeloid Leukemia Research (128 papers), Hematopoietic Stem Cell Transplantation (96 papers) and Acute Lymphoblastic Leukemia research (38 papers). Je‐Hwan Lee is often cited by papers focused on Acute Myeloid Leukemia Research (128 papers), Hematopoietic Stem Cell Transplantation (96 papers) and Acute Lymphoblastic Leukemia research (38 papers). Je‐Hwan Lee collaborates with scholars based in South Korea, United States and Japan. Je‐Hwan Lee's co-authors include Kyoo‐Hyung Lee, Jung‐Hee Lee, Miee Seol, Dae‐Young Kim, Chan‐Jeoung Park, WK Kim, KH Lee, Seongsoo Jang, Jung‐Shin Lee and H-S Chi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Je‐Hwan Lee

296 papers receiving 5.0k citations

Peers

Countries citing papers authored by Je‐Hwan Lee

Since Specialization

Citations

This map shows the geographic impact of Je‐Hwan Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Je‐Hwan Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Je‐Hwan Lee more than expected).

Fields of papers citing papers by Je‐Hwan Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Je‐Hwan Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Je‐Hwan Lee. The network helps show where Je‐Hwan Lee may publish in the future.

Co-authorship network of co-authors of Je‐Hwan Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Je‐Hwan Lee. A scholar is included among the top collaborators of Je‐Hwan Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Je‐Hwan Lee. Je‐Hwan Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Corticosteroid Therapy for Diffuse Alveolar Hemorrhage with Respiratory Failure in Hematologic Malignancies: A Retrospective Cohort Study 2025 ·Therapeutics and Clinical Risk Management ·(unknown), (unknown), Jin Won Huh, (unknown), Sang‐Bum Hong, Je‐Hwan Lee, Chae‐Man Lim, Kyoo‐Hyung Lee, Younsuck Koh	0
2	Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea 2023 ·Journal of Korean Medical Science ·Jin Seok Kim, Jun Ho Jang, Deog‐Yeon Jo, (unknown), Sung‐Soo Yoon, Je‐Hwan Lee, Sung‐Hyun Kim, Chul Won Choi, Ho‐Jin Shin, Min Kyoung Kim, Jae Hoon Lee, Yeung‐Chul Mun, Jee Hyun Kong, (unknown), (unknown), (unknown), (unknown), (unknown), Jong Wook Lee	3
3	Increased PD-1 expression of bone marrow T-cells in acute myeloid leukaemia patients after stem cell transplantation, and its association with overall survival 2023 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·(unknown), Chan‐Jeoung Park, Young‐Uk Cho, Seongsoo Jang, Min Young Lee, (unknown), Kyung Nam Koh, Ho Joon Im, Eun‐Ji Choi, Je‐Hwan Lee, Kyoo‐Hyung Lee	3
4	Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study 2023 ·The Korean Journal of Internal Medicine ·Dong Won Baek, Han‐Seung Park, Sang Kyun Sohn, Dae Young Kim, Inho Kim, Jae‐Sook Ahn, Young Rok, Se Ryeon Lee, Hyeon‐Seok Eom, Won-Sik Lee, Sung‐Hyun Kim, Ho Sup Lee, Yoo Jin Lee, Joon Ho Moon, Je‐Hwan Lee, (unknown)	5
5	Real-World Treatment Patterns and Clinical Outcomes in Korean Patients With AML Ineligible for First-Line Intensive Chemotherapy: A Subanalysis of the CURRENT Study, a Non-Interventional, Retrospective Chart Review 2023 ·Journal of Korean Medical Science ·Soo‐Mee Bang, Ka‐Won Kang, Ik‐Chan Song, (unknown), Yinghui Duan, (unknown), Je‐Hwan Lee	0
6	Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy ^* 2022 ·Leukemia & lymphoma ·Toshihiro Miyamoto, David Sanford, Ciprian Tomuleasa, Hui‐Hua Hsiao, (unknown), Anoop Enjeti, (unknown), Teresa Bernal, (unknown), Maria Paola Martelli, Birol Güvenç, (unknown), Yinghui Duan, (unknown), (unknown), Je‐Hwan Lee	8
7	Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib 2022 ·Blood Cancer Journal ·Alexander E. Perl, Naoko Hosono, Pau Montesinos, Nikolai A. Podoltsev, Giovanni Martinelli, Nicki Panoskaltsis, Christian Récher, Catherine C. Smith, Mark J. Levis, Stephen A. Strickland, Christoph Röllig, (unknown), Wen‐Chien Chou, Je‐Hwan Lee, Hisayuki Yokoyama, Nahla Hasabou, Qiaoyang Lu, Ramón V. Tiu, Jessica K. Altman	27
8	Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first‐line systemic treatment or best supportive care: A multicenter international study 2022 ·European Journal Of Haematology ·Tomoki� Ito, David Sanford, Ciprian Tomuleasa, Hui‐Hua Hsiao, (unknown), Anoop Enjeti, (unknown), Teresa Bernal, (unknown), Maria Paola Martelli, Birol Güvenç, Cat N. Bui, Alex J. Delgado, Yinghui Duan, (unknown), (unknown), Je‐Hwan Lee	6
9	Clinical features and outcomes of hypocellular acute myeloid leukemia in adults 2021 ·Medicine ·Ik‐Chan Song, Deog‐Yeon Jo, Hyeoung‐Joon Kim, Yoo Hong Min, Dae Sik Hong, Won-Sik Lee, Ho‐Jin Shin, Je‐Hwan Lee, Jinny Park, Hee‐Je Kim	1
10	Granulocytic and Monocytic Myeloid-Derived Suppressor Cells are Functionally and Prognostically Different in Patients with Chronic Myeloid Leukemia 2021 ·Annals of Laboratory Medicine ·(unknown), Chan‐Jeoung Park, Min‐Sun Kim, Young‐Uk Cho, Seongsoo Jang, Mi Hyun Bae, Jung‐Hee Lee, Je‐Hwan Lee, Kyung‐Nam Koh, Ho Joon Im	5
11	A comparison of coagulation test results from heparinized central venous catheter and venipuncture 2020 ·Blood Coagulation & Fibrinolysis ·Mijin Jeon, (unknown), (unknown), Kyoo‐Hyung Lee, Je‐Hwan Lee, (unknown)	5
12	Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of “RISK” Study 2017 ·Biology of Blood and Marrow Transplantation ·Jae-Ki Choi, Sung‐Yeon Cho, Sung‐Soo Yoon, (unknown), Sung‐Han Kim, Je‐Hwan Lee, Jin Seok Kim, June‐Won Cheong, Jun-Ho Jang, Bojung Seo, Young‐Joo Kim, Hyejung Lee, Juneyoung Lee, Jong Wook Lee, Dong‐Gun Lee	32
13	Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry 2016 ·Journal of Korean Medical Science ·Jun Ho Jang, Jin Seok Kim, Sung‐Soo Yoon, Je‐Hwan Lee, Yeo-Kyeoung Kim, Deog‐Yeon Jo, Joo Seop Chung, Sang Kyun Sohn, Jong Wook Lee	56
14	Diagnostic usefulness of dynamic changes of CMV-specific T-cell responses in predicting CMV infections in HCT recipients 2016 ·Journal of Clinical Virology ·Jiwon Jung, Hyunjung Lee, Sun‐Mi Kim, Young‐Ah Kang, Young‐Shin Lee, Yong Pil Chong, Heungsup Sung, Sang‐Oh Lee, Sang‐Ho Choi, Yang Soo Kim, Jun Hee Woo, Jung‐Hee Lee, Je‐Hwan Lee, Kyoo‐Hyung Lee, Sung‐Han Kim	8
15	JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis 2015 ·Journal of Korean Medical Science ·(unknown), Young‐Uk Cho, Mi Hyun Bae, Seongsoo Jang, Eul‐Ju Seo, Hyun-Sook Chi, Yunsuk Choi, Dae‐Young Kim, Jung‐Hee Lee, Je‐Hwan Lee, Kyoo‐Hyung Lee, Young-Mi Park, Jong‐Keuk Lee, Chan‐Jeoung Park	15
16	Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine 2012 ·Journal of Clinical Oncology ·Je‐Hwan Lee, Young‐Don Joo, Hawk Kim, Hun Mo Ryoo, Min Kyoung Kim, Gyeong‐Won Lee, Jung‐Hee Lee, Won Sik Lee, (unknown), (unknown), Myung Soo Hyun, Dae‐Young Kim, Sung-Doo Kim, Young Joo Min, Kyoo‐Hyung Lee	77
17	Efficacy and safety of low-dose ganciclovir preemptive therapy in allogeneic haematopoietic stem cell transplant recipients compared with conventional-dose ganciclovir: a prospective observational study 2012 ·Journal of Antimicrobial Chemotherapy ·So-Youn Park, Sang‐Oh Lee, Sang‐Ho Choi, Yang Soo Kim, Jun Hee Woo, Seunghee Baek, Heungsup Sung, Mi‐Na Kim, Dae‐Young Kim, Jung‐Hee Lee, Je‐Hwan Lee, Kyoo‐Hyung Lee, Sung‐Han Kim	14
18	A Case of Hemophagocytic Syndrome as a Complication of Acute Hepatitis A 2011 ·The Korean Journal of Internal Medicine ·(unknown), Dae‐Young Kim, Sung-Doo Kim, Jung‐Hee Lee, Je‐Hwan Lee, (unknown)	1
19	CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status 2010 ·Breast Cancer Research and Treatment ·Tae Hyun Kim, Choung‐Soo Kim, Je‐Hwan Lee, Se Jin Jang, Jung Jin Hwang, Seonggu Ro, (unknown), Jene Choi	9
20	Survival according to Treatment Modalities in 137 Patients with Aplastic Anemia 2003 ·Blood Research ·Hee-Jung Sohn, (unknown), (unknown), (unknown), (unknown), Eun-Kyung Kim, Gyeong‐Won Lee, Jae‐Lyun Lee, Min‐Hee Ryu, Seong‐Jun Choi, Je‐Hwan Lee, Sung‐Bae Kim, Sang‐We Kim, Kyoo‐Hyung Lee, Jung‐Shin Lee, Woo-Kun Kim, Cheolwon Suh	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact